Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: Vendit™ who wrote (1078)	3/6/1998 12:03:00 PM
From: cardiologist to be	Read Replies (2) \| Respond to of 1359

as i said on an earlier post, i like the people at the meeting i was at doubt redux as a cause of serious, permanent valvular damage. however, it is in the same class as phen/fen, thus is a accomplice. there were also several reports of people who continued taking phen/fen despite sign/symptoms of valve damage because they were averse to regaining the weight they had lost. it will be a nightmare to separate the different cases during litigation. a cardiologist from canada who shall remain nameless, specializing in this field of echocardiography, was offered 600,000/yr for a ten yr minimum by a group of class action attorneys, to leave his practice and devote his life to this case. he refused because he hates lawyers. i don't know, i might have accepted 6 million for a somewhat justifiable lawsuit.